Envoy Medical, Inc. (NASDAQ:COCHW) Sees Significant Decline in Short Interest

Envoy Medical, Inc. (NASDAQ:COCHW) saw a large decline in short interest in the month of September. As of September 30th, there was short interest totaling 2,168 shares, a decline of 93.3% from the September 15th total of 32,325 shares. Based on an average daily volume of 24,603 shares, the short-interest ratio is presently 0.1 days.

Envoy Medical Price Performance

Shares of NASDAQ:COCHW traded up $0.00 during midday trading on Friday, reaching $0.04. The company had a trading volume of 31,406 shares, compared to its average volume of 26,187. The company’s 50 day moving average price is $0.04 and its 200 day moving average price is $0.05. Envoy Medical has a 52-week low of $0.02 and a 52-week high of $0.10.

About Envoy Medical

Envoy Medical is a medical technology company focused on developing fully implanted hearing devices for people with hearing loss. The company’s technology is designed to be implanted beneath the skin, with the goal of providing hearing support without the external components used by many conventional hearing devices.

Its lead product is the Acclaim cochlear implant, a fully implanted device that uses the body’s natural anatomy to capture sound and stimulate the cochlea. The Acclaim is intended for adults with sensorineural hearing loss and has received Breakthrough Device designation from the U.S.